Filter
3025
Filtered Results: 3025
Text search:
World
Health
Organization
-
Regional
Office
for
Europe
Featured
Recommendations
267
New Publications
635
Language
Document type
No document type
1466
Studies & Reports
690
Guidelines
392
Manuals
189
Strategic & Response Plan
119
Fact sheets
52
Training Material
46
Situation Updates
44
Resource Platforms
11
Brochures
8
Infographics
5
Online Courses
2
App
1
Countries / Regions
Global
181
Western and Central Europe
161
Ukraine
103
Eastern Europe
76
Sierra Leone
51
Russia
49
Syria
45
Liberia
39
Nepal
37
Africa
37
Kenya
36
Myanmar / Burma
36
Latin America and the Carribbean
34
Eastern Europe and Central Asia
34
Ethiopia
34
India
34
Zambia
29
Uganda
27
South Africa
26
Ghana
25
South–East Asia Region
24
Nigeria
22
Asia
21
Germany
21
Bangladesh
20
Guinea
19
Tanzania
19
South Sudan
19
Middle East and North Africa
18
West and Central Africa
17
Malawi
16
East and Southern Africa
15
Moldova
15
Namibia
15
Rwanda
14
Tajikistan
13
Senegal
13
Mozambique
13
Burkina Faso
12
Philippines
12
Congo, Democratic Republic of
12
Pakistan
12
Afghanistan
11
Zimbabwe
11
Jordan
11
Thailand
10
Yemen
10
Somalia
10
North Macedonia
9
Albania
9
Venezuela
9
Lebanon
9
Indonesia
9
Lesotho
8
China
8
Kyrgyzstan
8
Cambodia
8
Western Pacific Region
8
Brazil
8
Georgia
8
Central African Republic
8
Eswatini/ Swaziland
8
Haiti
7
Romania
7
Poland
7
Botswana
7
Turkey
6
Cameroon
6
Armenia
6
Sri Lanka
6
Iraq
6
Benin
5
Kazakhstan
5
Iran
5
USA
5
Hungary
5
Vietnam
5
Greece
5
Laos
4
Estonia
4
Belarus
4
Sudan
4
Madagascar
4
Colombia
3
Mexico
3
Serbia
3
Guinea-Bissau
3
Turkmenistan
3
Jamaica
3
Côte d’Ivoire / Ivory Coast
3
Mali
3
Canada
2
Uzbekistan
2
Burundi
2
Peru
2
Morocco
2
Bulgaria
2
Croatia
2
Lithuania
2
Paraguay
2
United Kingdom
2
Portugal
2
Azerbaijan
2
Bosnia and Herzegovina
2
Papua New Guinea
2
Egypt
2
Slovakia
2
Palestine
2
Chad
2
Libya
2
Ecuador
2
North Korea
1
Gambia
1
Togo
1
Fiji
1
Niger
1
Vanuatu
1
Mongolia
1
Qatar
1
Mauritania
1
Dominican Republic
1
Ireland
1
Saudi Arabia
1
North America
1
Gabon
1
Belgium
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Israel
1
Latvia
1
Southern Africa
1
Argentina
1
Angola
1
Bhutan
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
696
Key Resources
236
Clinical Guidelines
219
Public Health
187
Women & Child Health
170
Capacity Building
40
Pharmacy & Technologies
26
Toolboxes
Mental Health
288
COVID-19
279
HIV
277
TB
192
Planetary Health
177
Conflict
138
Rapid Response
137
Disability
136
AMR
108
Refugee
98
Global Health Education
92
Caregiver
72
Ebola & Marburg
70
NTDs
60
Pharmacy
56
Health Financing Toolbox
51
NCDs
50
Natural Hazards
39
Zika
32
Specific Hazards
27
Malaria
17
Polio
17
Cholera
10
Social Ethics
9
Typhoon
4
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov...
Children continue to be exposed to powerful food marketing, which predominantly promotes foods high in saturated fatty acids, trans-fatty acids, free sugars and/or sodium and uses a wide variety of marketing strategies that are likely to appeal to children. Food marketing has a harmful impact on chi...
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
This guide provides an overview of the major elements that must be considered before, during and after the implementation of antigen-detecting rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2. This guide is complementary to policy guidance issued by the World Health Organization (WHO). The guide may ...
To improve survival and quality of life among the 2.5 million children living with HIV, a comprehensive package of prevention, care and treatment is required. This package should include management of infections such as pneumonia, diarrhoea, malaria and ear infections, as well as common opportunisti...
Communities can play a critical role in suicide prevention. Facilitating community engagement in suicide prevention is an important task. The toolkit is a step-by-step guide for communities to engage in suicide prevention activities and have ownership of the process and keep efforts sustained. It is...
The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria are part of a group of agencies working together to accelerate progress towards the health-related SDGs through the Global Action Plan for Healthy Lives and Well-being for All. Understanding patterns of inequal...
This global guidance was developed to support malaria-free countries and those that are close to malaria elimination to prevent re-establishment. The document outlines key concepts and principles for preventing re-establishment and provides guidance on strategies, interventions, planning and managem...
WHO has issued a new recommendation on the length of bladder catheterization following surgical repair of a simple obstetric urinary fistula. Currently the length of catheterization is not standard and ranges from 5 to 42 days. The new guidance recommends a 7–10 day period of bladder catheterizati...
The report is geared towards mayors, local government officials and city policy planners.It highlights key areas where city leaders can tackle the drivers of NCDs, including tobacco use, air pollution, poor diets and lack of exercise, and improve road safety.
From anti-tobacco actions in Beijing a...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence ...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
This purpose of this guide is to inform robust evaluations of the WHO training package – a package aimed at personnel whose primary role in health-care facilities is environmental cleaning, hereafter referred to as cleaners.
The WHO training package – Environmental cleaning and infection prev...
The objectives of this guideline are the same as those of the 2011 edition, namely to provide evidence-based normative guidance on interventions to improve adolescent morbidity and mortality by reducing the chances of early pregnancy and its resulting poor health outcomes. The specific objectives of...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria targets. The strategy outlines 4 strategic objectives ...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
